Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for braf protein, human (compound)
Most Correlated Studies
- Melanoma cells Ras or BRAF mutant treated with sorafenib and/or diclofenac
- Antitumor efficacy of GDC-0879 involving BRAF mutational status
- Gene expression in response to chemotherapy in human-melanoma cells
- Response to TNF-alpha in melanoma cell lines with different mutations
- Uveal melanoma cell lines reponses to selumetinib treatment
Most Relevant Literature
- Melanoma: Double BRAF mutation, double chance to treat?
- BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implic…
- Encorafenib (Braftovi) for metastatic colorectal cancer.
- Detection of an IGH-BRAF fusion in a patient with BRAF Val600Glu negative hairy cell leukemia.
- ASO Author Reflections: The Moment That BRAF V600E Mutation Starts Evolving into "Precision Oncosurg…
Most Relevant Clinical Trials
- Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
- Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Dis…
- HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
- Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
